Celltrion today announced that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is approved ...

South Korea's pharmaceutical giant Celltrion on Monday said that it has received approval from Canadian health authorities for a biosimilar treatment for allergic asthma.

Alvotech and Advanz Pharma have submitted a European marketing application for their golimumab biosimilar to treat ...

Celltrion today presented additional data from a Phase III randomized controlled trial (RCT) for CT-P41, a biosimilar candidate referencing PROLIA®/XGEVA® (denosumab) in postmenopausal women ...

Celltrion’s biosimilar marketing strategy in Europe has got seriously confusing after the firm asked to market its rituximab near-copy under four different brands. Its biosimilar of Roche’s ...

South Korea’s Celltrion has made its first major acquisition, buying a portfolio of drugs including diabetes and hypertension drugs from Takeda that will expand its expertise with small ...

Saviynt, a leading provider of cloud-native identity and governance platform solutions, today announced select financial and operating results, including Q3, with record revenues and a high contracted ...

As a passionate literacy advocate, he is taking a leading role in addressing the literacy gap across Illinois, championing initiatives that encourage reading and education for children. "Someone has ...

The Fair Trade Commission said it has imposed a fine of 46.765 billion won this year for detecting five cases of unfair support or defraudation of private ...

Shares jumped more than 2 percent on Tuesday to snap a four-session losing streak following the kickoff of investigations ...